Osteoporosis Market Drug Forecast and Analysis Research 2024: A $17.9 Billion Industry by 2033 - Focus on US, France, Germany, Italy, Spain, UK, Japan
19 juil. 2024 04h34 HE
|
Research and Markets
Dublin, July 19, 2024 (GLOBE NEWSWIRE) -- The "Osteoporosis: Seven-Market Drug Forecast and Market Analysis" report has been added to ResearchAndMarkets.com's offering.This report covers the 7MM...
Osteoporosis Prevalence Set to Escalate by 2033, New Epidemiology Forecast Reveals - Focus on US, France, Germany, Italy, Spain, UK, and Japan
29 mai 2024 07h56 HE
|
Research and Markets
Dublin, May 29, 2024 (GLOBE NEWSWIRE) -- The "Osteoporosis: Epidemiology Forecast to 2033" report has been added to ResearchAndMarkets.com's offering. Osteoporosis, a condition identified by...
Global Osteoporosis Clinical Trials Review 2023: Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End Point Status
31 janv. 2024 06h57 HE
|
Research and Markets
Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "Osteoporosis - Global Clinical Trials Review, 2023" clinical trials has been added to ResearchAndMarkets.com's offering.The clinical trial report...
Heart Failure Therapeutics Market is expected to generate a revenue of USD 15 billion by 2029 Globally at a 3.8% CAGR
15 sept. 2022 06h08 HE
|
Exactitude Consultancy
Luton, Bedfordshire, United Kingdom, Sept. 15, 2022 (GLOBE NEWSWIRE) -- Exactitude Consultancy, the market research and consulting wing of Ameliorate Digital Consultancy Private Limited has...
Osteoporosis Therapeutics Market to Top US$ 14 Bn Valuation by 2026: Fact.MR Analysis
15 mai 2022 20h00 HE
|
FACT.MR
United States, Rockville MD, May 15, 2022 (GLOBE NEWSWIRE) -- Demand for osteoporosis therapeutics is anticipated to increase at a CAGR of 2.9% from 2022 to 2026, as per this new analysis by...
Osteoporosis Therapeutics in Asia-Pacific (APAC) Markets to 2022: Industry Size, Shares, Trends, Opportunities, Survey and Forecast: ResearchMoz
22 août 2016 06h30 HE
|
Researchmoz Global Pvt Ltd
Albany, NY, Aug. 22, 2016 (GLOBE NEWSWIRE) -- Osteoporosis, the most common metabolic bone disease, is characterized by low bone mass, microarchitectural deterioration of bone tissue, and a...